Freeline Therapeutics Holdings plc (FRLN) Reports FY 2022 Loss of $1.50
Tweet
Share
E-mailGet Alerts FRLN Hot Sheet
Join SI Premium – FREE
Freeline Therapeutics Holdings plc (NASDAQ: FRLN) reported Q4 EPS of ($1.50).
For earnings history and earnings-related data on Freeline Therapeutics Holdings plc (FRLN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Quantum BioPharma gets FDA nod for Lucid-MS Phase 2 MS trial
- Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
